Zobrazeno 1 - 10
of 3 845
pro vyhledávání: '"Ducray, F."'
Autor:
Funck-Brentano T; Department of Rheumatology, National Reference Center for Rare Bone Disease in Adults, Lariboisière Hospital, APHP.Nord, France; Inserm U1132, BIOSCAR, F-75010 Paris, Université Paris Cité, Paris, France. Electronic address: thomas.funck-brentano@aphp.fr., Cohen-Solal M; Department of Rheumatology, National Reference Center for Rare Bone Disease in Adults, Lariboisière Hospital, APHP.Nord, France; Inserm U1132, BIOSCAR, F-75010 Paris, Université Paris Cité, Paris, France., Ducray F; Department of Neuro-oncology, Hospices Civils de Lyon, Lyon, France; LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard, France., Mandonnet E; Department of Neurosurgery, Lariboisière Hospital, APHP.Nord, France; Frontlab, CNRS UMR 7225, INSERM U1127, Paris Brain Institute (ICM), Paris, France; Université Paris Cité, Paris, France.
Publikováno v:
Bone [Bone] 2024 Nov; Vol. 188, pp. 117221. Date of Electronic Publication: 2024 Aug 02.
Autor:
Figarella-Branger D; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, GlioME Team, Marseille, France.; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France., Colin C; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, GlioME Team, Marseille, France.; Aix-Marseille Univ, Réseau PrEclinique et TRAnslationnel de Recherche en Neuro-Oncologie, Plateforme PETRA'TECH', Marseille, France., Mokhtari K; AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuropathologie-Escourolle, F-75013 Paris, France.; Sorbonne Université, Inserm, CNRS, UMR S 1127, Paris Brain Institute (ICM), Paris, France., Uro-Coste E; Department of Pathology, Toulouse University Hospital, Toulouse, France.; Université Paul Sabatier, Toulouse III, Toulouse, France.; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France., Idbaih A; Sorbonne Université, Inserm, CNRS, UMR S 1127, Paris Brain Institute (ICM), Paris, France.; AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuro-Oncologie, F-75013 Paris, France.; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière - Charles Foix, Département de Santé Publique, Unité de Recherche Clinique Pitié-Salpêtrière-Charles Foix, Paris, France., Appay R; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, GlioME Team, Marseille, France.; APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France., Tabouret E; Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, GlioME Team, Marseille, France.; APHM, CHU Timone, Service de Neuro-Oncologie, Marseille, France.; Aix-Marseille Univ, Réseau PrEclinique et TRAnslationnel de Recherche en Neuro-Oncologie, Plateforme PE'TRANSLA', Marseille, France., Touat M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Paris Brain Institute (ICM), Paris, France.; AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuro-Oncologie, F-75013 Paris, France., Seyve A; Service de Neuro-Oncologie, Hôpital Neurologique, Hospices Civils de Lyon, 69008 Lyon, France., Carpentier C; Sorbonne Université, Inserm, CNRS, UMR S 1127, Paris Brain Institute (ICM), Paris, France., Dehais C; Sorbonne Université, Inserm, CNRS, UMR S 1127, Paris Brain Institute (ICM), Paris, France.; AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuro-Oncologie, F-75013 Paris, France., Ducray F; Service de Neuro-Oncologie, Hôpital Neurologique, Hospices Civils de Lyon, 69008 Lyon, France.; Centre de Recherche en Cancérologie UMR INSERM 1052 CNRS 5286, Université Claude Bernard Lyon 1, 69008 Lyon, France.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Oct 21. Date of Electronic Publication: 2024 Oct 21.
Autor:
Gkasdaris G; Department of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France., Berthiller J; Department of Research and Clinical Epidemiology-Public Health, Hospices Civils de Lyon, 69677 Bron, France., Guyotat J; Department of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France., Jouanneau E; Department of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.; Faculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.; Cancer Initiation and Tumoral Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, 69008 Lyon, France., Gallet C; Department of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France., Meyronet D; Faculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.; Cancer Initiation and Tumoral Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, 69008 Lyon, France.; Department of Neuropathology, Groupement Hospitalier Est, Hospices Civils de Lyon, 69677 Bron, France., Thomas L; Department of Neuro-Oncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France., Cartalat S; Department of Neuro-Oncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France., Seyve A; Faculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.; Department of Neuro-Oncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France., Honnorat J; Faculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.; Department of Neuro-Oncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.; MELIS Institute-Team Synaptopathies and Autoantibodies, INSERM U1314, UMR CNRS 5284, 69677 Bron, France., Ducray F; Faculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.; Cancer Initiation and Tumoral Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, 69008 Lyon, France.; Department of Neuro-Oncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France., Picart T; Department of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677 Bron, France.; Faculty of Medicine, University Claude Bernard Lyon I, 69100 Villeurbanne, France.; Cancer Initiation and Tumoral Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, 69008 Lyon, France.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Oct 12; Vol. 16 (20). Date of Electronic Publication: 2024 Oct 12.
Autor:
van den Bent MJ; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands., French PJ; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Brat D; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Tonn JC; Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Germany., Touat M; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, Paris Brain Institute, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France., Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, USA., Young RJ; Neuroradiology Service, Department of Radiology, Memorial Sloan Kettering Cancer, New York, New York, USA., Pallud J; Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, IMA-Brain, Université Paris Cité, Paris, France.; Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne, Paris, France., von Deimling A; Department of Neuropathology, University Hospital Medicine and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Sahm F; Department of Neuropathology, University Hospital Medicine and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Figarella Branger D; DFB Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France., Huang RY; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Weller M; Department of Neurology & Brain Tumor Center, University Hospital Zurich & University of Zurich, Zurich, Switzerland., Mellinghoff IK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Cloughsey TF; Department of Neurology, TC David Geffen School of Medicine at UCLA, Los Angeles, USA., Huse JT; Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aldape K; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Reifenberger G; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany., Youssef G; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Karschnia P; German Cancer Consortium (DKTK), Partner Site Munich, Germany.; Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany., Noushmehr H; Department of Neurosurgery, Henry Ford Hospital+Michigan State University, Detroit, Michigan, USA., Peters KB; Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA., Ducray F; Inserm U1052, CNRS UMR5286, Université Claude Bernard Lyon, Lyon, France.; Hospices Civils de Lyon, Service de neuro-oncologie, LabEx Dev2CAN, Centre de Recherche en Cancérologie de Lyon, France., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1805-1822.
Autor:
Kacimi SEO; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Sorbonne Université, CinBioS, UMS 37 PASS, INSERM, Paris, France., Dehais C; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Feuvret L; Hospices Civils de Lyon, Radiotherapy Department, Bron, France., Chinot O; Department of Neuro-Oncology, Aix-Marseille Université, CHU Timone, AP-HM, Marseille, France., Carpentier C; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France., Bronnimann C; Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France., Vauleon E; Centre Eugène Marquis, Medical Oncology, INSERM U1242, University of Rennes, Rennes, France., Djelad A; Department of Neurosurgery, University Hospital of Lille, Lille, France., Cohen-Jonathan Moyal E; Department of Radiation Oncology, Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.; Institut National de la Santé et de la Recherche Médicale U1037, Centre de Recherche contre le Cancer de Toulouse, Toulouse, France.; Université Toulouse III Paul Sabatier, Toulouse, France., Langlois O; Department of Neurosurgery, University Hospital of Rouen, Rouen, France., Campone M; Institut de Cancérologie de l'Ouest-René Gauducheau, Centre de Recherche en Cancérologie, Saint Herblain, France., Ducloie M; Department of Neurology, CHU de Caen Normandie, Caen, France., Noel G; Radiation Oncology Department, Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, France.; Radiobiology Laboratory, Centre Paul Strauss, IIMIS - Imagerie Multimodale Integrative en Santé, ICube, Strasbourg University, Strasbourg, France., Cuzzubbo S; Neurology Department, APHP, University Hospital Saint Louis, Paris, France.; Université Paris Cité, Paris, France., Taillandier L; Neurology Department, CHU de Nancy, Nancy, France., Ramirez C; Neurology Department, North Hospital, University Hospital of Saint Etienne, Saint-Priest-en-Jarez, France., Younan N; Neurology Department, Hôpital Foch, Suresnes, France., Menei P; Neurosurgery Department, CHU Angers, Angers, France., Dhermain F; Radiotherapy Department, Institut Gustave Roussy, Villejuif, France., Desenclos C; Neurosurgery Department, Hôpital Nord, CHU Amiens, Amiens, France., Ghiringhelli F; Centre Georges-François Leclerc, Medical Oncology, Dijon, France., Bourg V; Neurology Department, CHU Nice, Nice, France., Ricard D; Neurology department, Hôpital National d'Instruction des Armées Percy, Service de Santé des Armées, Clamart, France., Faillot T; Neurosurgery Department, AP-HP, Hôpital Beaujon, Clichy, France., Appay R; Department of Pathology and Neuropathology, Aix-Marseille University, CHU Timone, AP-HM, Marseille, France., Tabouret E; Department of Neuro-Oncology, Aix-Marseille Université, CHU Timone, AP-HM, Marseille, France., Nichelli L; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuroradiologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Mathon B; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neurochirurgie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Thomas A; Service de Radiothérapie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Tran S; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuropathologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Bielle F; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuropathologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Alentorn A; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Iorgulescu JB; Molecular Diagnostics Laboratory, Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Boëlle PY; Sorbonne Université, CinBioS, UMS 37 PASS, INSERM, Paris, France., Labreche K; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Sorbonne Université, CinBioS, UMS 37 PASS, INSERM, Paris, France., Hoang-Xuan K; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Sanson M; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Idbaih A; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Figarella-Branger D; Department of Pathology and Neuropathology, Aix-Marseille University, CHU Timone, AP-HM, Marseille, France., Ducray F; Neuro-Oncology Unit, Hospices Civils de Lyon, Lyon, France.; LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard, Villeurbanne, France., Touat M; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.; Department of Neurology, Brigham and Women's Hospital, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 02, pp. JCO2400049. Date of Electronic Publication: 2024 Oct 02.
Autor:
Roth P; Department of Neurology and Brain Tumor Center, University Hospital Zurich, Zurich, Switzerland.; Department of Neurology, University of Zurich, Zurich, Switzerland., Gorlia T; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Reijneveld JC; Department of Neurology & Brain Tumor Center, Amsterdam University Medical Centers, Amsterdam, The Netherlands., de Vos F; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands., Idbaih A; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France., Frenel JS; Department of Medical Oncology, Institut de Cancerologie de L'Ouest, Saint-Herblain, France., Le Rhun E; CHU Lille, Service de neurochirurgie, Lille, France.; Univ. Lille, Inserm, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Lille, France.; Department of Neurosurgery & Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Sepulveda JM; Neuro-Oncology Unit, Department of Medical Oncology, Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain., Perry J; Division of Neurology, Sunnybrook HSC, University of Toronto, Toronto, Ontario, Canada., Masucci GL; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada., Freres P; Department of Medical Oncology, University Hospital of Liege, Liege, Belgium., Hirte H; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Seidel C; Department of Radiation Oncology, University Hospital Leipzig, Leipzig, Germany., Walenkamp A; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Lukacova S; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Meijnders P; Department of Radiation Oncology, Iridium Network Antwerpen, University of Antwerp, Antwerp, Belgium., Blais A; Service d'hématologie et d'oncologie, Centre intégré de cancérologie du CHU de Québec - Université Laval, Québec City, Québec, Canada., Ducray F; Department of Neuro-Oncology, Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France.; Lyon Cancer Research Center (CRCL) UMR INSERM 1052 CNRS 5286, Lyon, France., Verschaeve V; Department of Medical Oncology, GHDC Grand Hopital de Charleroi, Charleroi, Belgium., Nicholas G; University of Ottawa, Division of Medical Oncology, Ottawa, Ontario, Canada., Balana C; Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain., Bota DA; Chao Family Comprehensive Cancer Center and Department of Neurology, University of California, Irvine, California, USA., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Nuyens S; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Dhermain F; Department of Radiation Oncology, University Hospital Gustave Roussy, Villejuif, France., van den Bent M; Brain Tumor Center at ErasmusMC Cancer Institute, Rotterdam, The Netherlands., O'Callaghan CJ; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada., Vanlancker M; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Mason W; Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Weller M; Department of Neurology and Brain Tumor Center, University Hospital Zurich, Zurich, Switzerland.; Department of Neurology, University of Zurich, Zurich, Switzerland.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Sep 05; Vol. 26 (9), pp. 1670-1682.
Autor:
Guidara S; Department of Medical Genetics, Hedi Chaker Hospital, Sfax, Tunisia. souhir.guidara89@gmail.com., Seyve A; Department of Neurooncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France., Poncet D; Department of Pathology, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France.; Institut Neuro Myo Gène (INMG), Pathophysiology and Genetics of Neuron and Muscle (PGNM), Université Claude Bernard Lyon 1, CNRS UMR 5261-INSERM U1315, Neuron-Muscle interaction team, Lyon, France., Leonce C; Department of Pathology, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France.; Centre Léon Bérard, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France., Bringuier PP; Department of Pathology, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France.; Université Claude Bernard Lyon 1, Villeurbanne, France., McLeer A; Service d'Anatomie et Cytologie Pathologiques CHU Grenoble Alpes, Institute for Advanced Biosciences UGA, Université Grenoble Alpes, INSERM U1209/CNRS 5309, Grenoble, France., Sturm D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany., Cartalat S; Department of Neurooncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France., Picart T; Centre Léon Bérard, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Université Claude Bernard Lyon 1, Villeurbanne, France.; Department of Neurosurgery, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France., Ferrari A; Gilles Thomas Bioinformatics Platform, Synergie Lyon Cancer, Cancer Research Center of Lyon, Centre Léon Bérard FR, Lyon, France., Hench J; Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Frank S; Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Meyronet D; Department of Pathology, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France.; Université Claude Bernard Lyon 1, Villeurbanne, France.; Cancer Initiation and Tumoral Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, Lyon, France., Ducray F; Department of Neurooncology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.; Université Claude Bernard Lyon 1, Villeurbanne, France.; Cancer Initiation and Tumoral Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, Lyon, France., Barritault M; Department of Pathology, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France. marc.barritault@chu-lyon.fr.; Cancer Initiation and Tumoral Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, Lyon, France. marc.barritault@chu-lyon.fr.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2024 Sep; Vol. 169 (2), pp. 391-398. Date of Electronic Publication: 2024 Jun 27.
Autor:
DE Alcubierre D; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude Bernard Lyon1 University, Lyon, France., Carretti AL; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Department of Endocrinology, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est Hospices Civils de Lyon, Bron, France., Ducray F; Service of Neuro-Oncology, Groupement Hospitalier Est Hospices Civils de Lyon, Bron, France., Jouanneau E; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude Bernard Lyon1 University, Lyon, France.; Department of Pituitary and Skull Base Neurosurgical, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est Hospices Civils de Lyon, Bron, France., Raverot G; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude Bernard Lyon1 University, Lyon, France - gerald.raverot@chu-lyon.fr.; Department of Endocrinology, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est Hospices Civils de Lyon, Bron, France., Ilie MD; Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude Bernard Lyon1 University, Lyon, France.; Department of Endocrinology, C.I. Parhon National Institute of Endocrinology, Bucharest, Romania.
Publikováno v:
Minerva endocrinology [Minerva Endocrinol (Torino)] 2024 Sep; Vol. 49 (3), pp. 321-334. Date of Electronic Publication: 2024 Jan 19.
Autor:
Berhouma, M., Dumot, C., Picart, T., Vasiljevic, A., Ducray, F., Faure-Conter, C., Guyotat, J.
Publikováno v:
In EMC – Neurologia May 2020 20(2):1-15